Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03297021 · ClinicalTrials.gov registry record · Phase 4
Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting
A Phase 4 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 4
- Development phase
- 141
- Enrollment target
NCT03297021 is a Phase 4 study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 141 participants.
The verdict
NCT03297021, a Phase 4 study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 141 participants
- Enrollment target
Study Summary
The aim is to evaluate the effectiveness of three different regimens of prophylactic ondansetron on the incidence and severity of post-operative nausea and vomiting.
Interventions
- DRUG Ondansetron 8mg
- DRUG Ondansetron 4 MG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2017-10-23 |
| Est. Completion | 2019-04-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03297021
The ClinicalTrials.gov registry entry for NCT03297021 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ondansetron 8mg is the first listed.
NCT03297021 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03297021 about?
NCT03297021 is a clinical study titled "Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting". The aim is to evaluate the effectiveness of three different regimens of prophylactic ondansetron on the incidence and severity of post-operative nausea and vomiting.
What is the current status of trial NCT03297021?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 141 participants. The study started on 2017-10-23. Estimated completion is 2019-04-05.
What interventions are being tested in trial NCT03297021?
The interventions under investigation include: Ondansetron 8mg (DRUG), Ondansetron 4 MG (DRUG).
Who is sponsoring clinical trial NCT03297021?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.